vs
Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and Porch Group, Inc. (PRCH). Click either name above to swap in a different company.
Porch Group, Inc. is the larger business by last-quarter revenue ($121.1M vs $75.5M, roughly 1.6× PUMA BIOTECHNOLOGY, INC.). On growth, Porch Group, Inc. posted the faster year-over-year revenue change (100.0% vs 27.7%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 26.4%).
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
Porch is a website that tries to connect homeowners with local home improvement contractors. The site features advice articles, cost guide, and online booking for over 160 home projects.
PBYI vs PRCH — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $75.5M | $121.1M |
| Net Profit | — | $-4.7M |
| Gross Margin | 69.3% | 52.7% |
| Operating Margin | 22.7% | 34.7% |
| Net Margin | — | -3.9% |
| Revenue YoY | 27.7% | 100.0% |
| Net Profit YoY | — | 2.0% |
| EPS (diluted) | $0.26 | $-0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $121.1M | ||
| Q4 25 | $75.5M | $112.3M | ||
| Q3 25 | $54.5M | $115.1M | ||
| Q2 25 | $52.4M | $107.0M | ||
| Q1 25 | $46.0M | $84.5M | ||
| Q4 24 | $59.1M | $75.3M | ||
| Q3 24 | $80.5M | $77.7M | ||
| Q2 24 | $47.1M | $75.9M |
| Q1 26 | — | $-4.7M | ||
| Q4 25 | — | $-3.5M | ||
| Q3 25 | $8.8M | $-10.9M | ||
| Q2 25 | $5.9M | $2.6M | ||
| Q1 25 | $3.0M | $8.4M | ||
| Q4 24 | — | $30.5M | ||
| Q3 24 | $20.3M | $14.4M | ||
| Q2 24 | $-4.5M | $-64.3M |
| Q1 26 | — | 52.7% | ||
| Q4 25 | 69.3% | 99.5% | ||
| Q3 25 | 77.7% | 75.6% | ||
| Q2 25 | 76.5% | 70.9% | ||
| Q1 25 | 77.1% | 77.4% | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | 79.4% | ||
| Q2 24 | 77.4% | 22.1% |
| Q1 26 | — | 34.7% | ||
| Q4 25 | 22.7% | 14.7% | ||
| Q3 25 | 17.6% | 14.2% | ||
| Q2 25 | 12.7% | 4.7% | ||
| Q1 25 | 8.7% | -1.5% | ||
| Q4 24 | 22.6% | 33.3% | ||
| Q3 24 | 27.4% | -3.2% | ||
| Q2 24 | -4.6% | -69.2% |
| Q1 26 | — | -3.9% | ||
| Q4 25 | — | -3.1% | ||
| Q3 25 | 16.2% | -9.4% | ||
| Q2 25 | 11.2% | 2.4% | ||
| Q1 25 | 6.5% | 9.9% | ||
| Q4 24 | — | 40.5% | ||
| Q3 24 | 25.2% | 18.5% | ||
| Q2 24 | -9.6% | -84.8% |
| Q1 26 | — | $-0.04 | ||
| Q4 25 | $0.26 | $0.00 | ||
| Q3 25 | $0.17 | $-0.10 | ||
| Q2 25 | $0.12 | $0.00 | ||
| Q1 25 | $0.06 | $0.07 | ||
| Q4 24 | $0.40 | $0.34 | ||
| Q3 24 | $0.41 | $0.12 | ||
| Q2 24 | $-0.09 | $-0.65 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $97.5M | $68.4M |
| Total DebtLower is stronger | $22.7M | $391.3M |
| Stockholders' EquityBook value | $130.3M | $26.3M |
| Total Assets | $216.3M | $806.6M |
| Debt / EquityLower = less leverage | 0.17× | 14.87× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $68.4M | ||
| Q4 25 | $97.5M | $57.3M | ||
| Q3 25 | $94.4M | $85.0M | ||
| Q2 25 | $96.0M | $79.8M | ||
| Q1 25 | $93.2M | $70.4M | ||
| Q4 24 | $101.0M | $191.7M | ||
| Q3 24 | $96.7M | $238.6M | ||
| Q2 24 | $96.8M | $308.4M |
| Q1 26 | — | $391.3M | ||
| Q4 25 | $22.7M | $392.8M | ||
| Q3 25 | $34.0M | $387.1M | ||
| Q2 25 | $45.3M | $394.1M | ||
| Q1 25 | $56.7M | $409.2M | ||
| Q4 24 | $68.0M | $403.9M | ||
| Q3 24 | $79.3M | $399.0M | ||
| Q2 24 | $90.7M | $436.8M |
| Q1 26 | — | $26.3M | ||
| Q4 25 | $130.3M | $-24.6M | ||
| Q3 25 | $115.3M | $-27.9M | ||
| Q2 25 | $104.7M | $-29.3M | ||
| Q1 25 | $97.1M | $-52.4M | ||
| Q4 24 | $92.1M | $-43.2M | ||
| Q3 24 | $71.1M | $-77.0M | ||
| Q2 24 | $48.5M | $-101.9M |
| Q1 26 | — | $806.6M | ||
| Q4 25 | $216.3M | $797.4M | ||
| Q3 25 | $202.9M | $787.7M | ||
| Q2 25 | $194.9M | $770.7M | ||
| Q1 25 | $196.2M | $802.3M | ||
| Q4 24 | $213.3M | $814.0M | ||
| Q3 24 | $220.7M | $867.3M | ||
| Q2 24 | $205.0M | $876.1M |
| Q1 26 | — | 14.87× | ||
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | — |
| Free Cash FlowOCF − Capex | $14.4M | — |
| FCF MarginFCF / Revenue | 19.1% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $41.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $14.4M | $1.2M | ||
| Q3 25 | $9.7M | $40.8M | ||
| Q2 25 | $14.1M | $35.6M | ||
| Q1 25 | $3.6M | $-11.2M | ||
| Q4 24 | $15.6M | $-26.6M | ||
| Q3 24 | $11.0M | $12.4M | ||
| Q2 24 | $1.0M | $-26.0M |
| Q1 26 | — | — | ||
| Q4 25 | $14.4M | $1.1M | ||
| Q3 25 | $9.7M | $40.7M | ||
| Q2 25 | $14.1M | $35.4M | ||
| Q1 25 | $3.6M | $-11.2M | ||
| Q4 24 | $15.6M | $-26.8M | ||
| Q3 24 | $11.0M | $12.2M | ||
| Q2 24 | $1.0M | $-26.0M |
| Q1 26 | — | — | ||
| Q4 25 | 19.1% | 1.0% | ||
| Q3 25 | 17.7% | 35.4% | ||
| Q2 25 | 26.8% | 33.0% | ||
| Q1 25 | 7.7% | -13.3% | ||
| Q4 24 | 26.4% | -35.6% | ||
| Q3 24 | 13.7% | 15.7% | ||
| Q2 24 | 2.1% | -34.3% |
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.0% | 0.1% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.0% | 0.3% | ||
| Q3 24 | 0.0% | 0.3% | ||
| Q2 24 | 0.0% | 0.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | 13.79× | ||
| Q1 25 | 1.21× | -1.33× | ||
| Q4 24 | — | -0.87× | ||
| Q3 24 | 0.54× | 0.86× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
